Vimarsana
Biggest News Aggregation in the World

Page 12 - Path Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Path Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Path Capital Today - Breaking & Trending Today

Q2 2023 EPS Estimates for NOV Inc. Increased by Zacks Research (NYSE:NOV) - Vimarsana News

Q2 2023 EPS Estimates for NOV Inc. Increased by Zacks Research (NYSE:NOV)

NOV Inc. (NYSE:NOV – Get Rating) – Zacks Research boosted their Q2 2023 earnings per share (EPS) estimates for NOV in a note issued to investors on Friday, June 2nd. Zacks Research analyst N. Choudhury now forecasts that the oil and gas exploration company will post earnings of $0.27 per share for the quarter, up […]

The Chemours Company to sell glycolic acid business for $137 million - Vimarsana News

The Chemours Company to sell glycolic acid business for $137 million

The Chemours Company has entered into a definitive agreement to sell its Glycolic Acid business for $137 million in cash to PureTech Scientific Inc., a company founded and backed by Iron Path Capi ...

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million – Consumer Electronics Net - Vimarsana News

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million – Consumer Electronics Net

Consumerelectronicsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from consumerelectronicsnet.com Daily Mail and Mail on Sunday newspapers.

Goldman Sachs Initiates Coverage of SeaWorld Entertainment With Buy Recommendation – 24/7 Wall St. - Vimarsana News

Goldman Sachs Initiates Coverage of SeaWorld Entertainment With Buy Recommendation – 24/7 Wall St.

Goldman Sachs has initiated coverage of SeaWorld Entertainment with a Buy recommendation.

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million - Vimarsana News

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million

The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials has entered into a... | June 10, 2023